CorVel Corp (CRVL)
🔔 Watch stock
symbol.quality_heading
Business model, numbers and balance sheet hold up to our review. Whether the current price supports an entry is a separate question — it hangs on the price, not on the company.
The quality of this business is documented and not in dispute: revenue has grown for three years, the margin has improved under its own power from 9.6 to 11.5 percent, the profit is backed by cash ($155.6 million of operating cash flow against $110.3 million of reported net income), the balance sheet carries no financial debt and 61.3 percent equity, and no customer accounts for 10 percent of revenue. What we criticise are not questions of substance but of capital allocation and power: a buyback that retires a net 0.88 percent of the shares, and a 37.99 percent shareholder who also decides who is nominated to the board. The price, at roughly 28 times earnings, is no bargain either — but price does not set this rating. The decision is yours.
symbol.quality_note
CorVel reviews the bills that pile up after American workplace injuries. In the year ended March 31, 2026 the company earned $110.3 million, more than ever before, held $233.1 million in cash and says it has carried virtually no interest-bearing debt for 35 years. The stock still closed 53 percent below its split-adjusted all-time high of February 5, 2025 on July 24, 2026 — which is exactly why it shows up in a turnaround scanner. Except that what turned here is the price, not the business. We read the annual report, the proxy statement and the June 1, 2026 filing, and we find a buyback that barely moves the needle, a shareholder with 38 percent, and a chief executive the annual report does not yet know about. No advice — just the question of who was ever sick here.
Read the analysis
Stock Watch
This analysis is as of July 26, 2026. Stock Watch will tell you what's changed at CRVL since then.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 10 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 60.10 $ — 30% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
Sells AIKI steckt in der bezahlten Dienstleistung selbst: Der Geschäftsbericht 2026 beschreibt in Item 1 einen eigenen KI-Motor mit über 100 Millionen Regeln als Kern der Rechnungsprüfung und KI-Technik im Kundenportal CareMC — die Sparte Network Solutions, in der diese Rechnungsprüfung sitzt, wuchs laut MD&A im Geschäftsjahr 2026 um 15 Prozent auf 362 Millionen US-Dollar.
View the full file — quotes, sources, reviewed filings
„CorVel applies certain technology, including artificial intelligence, machine learning, and natural language processing, to enhance the management of episodes of care and the related health-care costs."
CorVel setzt bestimmte Technologien ein, darunter künstliche Intelligenz, maschinelles Lernen und die Verarbeitung natürlicher Sprache, um die Steuerung von Behandlungsepisoden und die damit verbundenen Gesundheitskosten zu verbessern.
„CorVel’s artificial intelligence engine includes over 100 million individual rules, which offers a comprehensive, paperless solution that surpasses the capabilities of traditional, manual bill review processes."
CorVels Motor für künstliche Intelligenz umfasst über 100 Millionen einzelne Regeln und bietet damit eine umfassende, papierlose Lösung, die die Möglichkeiten herkömmlicher, manueller Rechnungsprüfung übertrifft.
„Using artificial intelligence technology, the website provides situation alerts and event triggers, to facilitate prompt and effective decisions."
Mithilfe von Technik für künstliche Intelligenz liefert die Website Situationswarnungen und Ereignisauslöser, um schnelle und wirksame Entscheidungen zu ermöglichen.
„We have internal policies governing the use of artificial intelligence by our employees designed to protect the Company from breaches of data privacy, liability and regulatory enforcement risk; however, if our employees violate these policies, it could expose us to such risks."
Wir haben interne Richtlinien für den Einsatz künstlicher Intelligenz durch unsere Beschäftigten, die das Unternehmen vor Verstößen gegen den Datenschutz, vor Haftung und vor aufsichtsrechtlicher Verfolgung schützen sollen; verstoßen unsere Beschäftigten jedoch gegen diese Richtlinien, könnten wir genau diesen Risiken ausgesetzt sein.
Filings Reviewed: 10-K 2026-05-22 · 10-Q 2026-02-05 · 10-Q 2025-11-06 · 10-Q 2025-08-07 · 10-K 2025-05-23 · 10-Q 2025-02-06
Rated on July 26, 2026 · How the Rating Is Built
What the Earnings Calls Reveal
Red flags Inconsistent disclosureAcross the four calls reviewed, CorVel delivers solid operating numbers: fiscal 2026 revenue rose 7 percent to 959 million dollars and earnings per share 17 percent to 2.14 dollars. The surrounding communication does not keep pace. Management issues no numerical guidance at all, exactly two questions were answered across four calls, both submitted in writing through the web platform, and the company's own buyback figures contradict each other between the December and March quarters of fiscal 2026. Anyone valuing CorVel largely has to do it without help from management.
4 calls reviewed, 2025-Q3 through 2026-Q4 · As of August 2, 2026
Buyback figures do not add up
On the 2026-Q3 call CorVel reports 114.9 million shares repurchased since inception for an aggregate 868 million dollars, an average of 7.55 dollars per share. One quarter later, on the 2026-Q4 call, the share count is 115.3 million, the aggregate stays unchanged at 868 million dollars, yet the stated average price rises to 7.70 dollars. The same call reports 366,306 shares bought in the March quarter alone for 20 million dollars. Arithmetically the aggregate should be roughly 888 million dollars, which is also the figure consistent with the quoted average price. One of the two statements is wrong, and neither was corrected.
Level of detail varies from call to call
On the 2025-Q3 call CorVel gives revenue and gross profit separately for Patient Management (146 million dollars, up 11 percent) and Network Solutions (82 million dollars, up 16 percent). On the 2026-Q2 call the growth contributions are split again: 4 million dollars from claims operations, 12 million from Network Solutions. When the 2026-Q3 call brings a question asking for exactly that split, in the quarter with only 3 percent revenue growth, the answer is that CorVel operates in a single segment and as a policy does not report its products separately. The next call, 2026-Q4, sticks to that line and gives no product-level figures either, yet describes the two areas separately for the fiscal year: double-digit growth at Network Solutions, low single digit at Patient Management. That is not a breach of the stated policy, but it is an uneven level of disclosure: breakdowns appear when management volunteers them and are withheld when someone asks.
Four calls, two questions answered
The 2025-Q3 call ends without a question period at all. On the 2026-Q2 call the question period is opened and closed again without a single question. The 2026-Q3 call answers two questions submitted in writing through the web platform, and the 2026-Q4 call takes none. Asked the only substantive question, why revenue growth stalled, the CEO answers without a single number: they look at the fundamentals, growth over ten years is 'not a straight line necessarily', and a small cycle change says nothing about future results. General reasons do appear on the same call: short-term operational factors, the normalised effective tax rate and the industry-wide decline in workplace injuries. The tax rate, however, explains earnings, not revenue. A quantified explanation for the drop from 13 percent growth in the December 2024 quarter to 3 percent in the December 2025 quarter is missing on all four calls.
Negative one-time items stay unnamed
On the 2026-Q2 call, one-time events are said to have softened the earnings increase by roughly 9 percentage points, equivalent to about 4 cents per share. Which events those were is never disclosed. On the 2026-Q4 call, by contrast, a positive one-time item at the CERiS unit is named and quantified: accelerated post-payment recoveries from a large payer engagement, 2 cents per share, explicitly labelled a timing benefit. The future tailwind mentioned in the same passage refers to that engagement and to further payer wins, not to the pulled-forward amount, so there is no contradiction there. What remains is the asymmetry: positive one-time items get named, negative ones do not.
Rotating metrics, rotating buzzwords
Every call introduces new success metrics and drops the old ones. The 2026-Q3 call features net revenue retention of 100 percent and a 44 percent close rate; on the 2026-Q4 call both are gone, replaced by new bookings up 56 percent and RFP activity up 20 percent. The technology vocabulary behaves the same way: generative AI in 2025-Q3, 'Agentic AI' in 2026-Q2 with the claim it will matter more than generative AI, no mention of the term at all in 2026-Q3, and a platform called CorVel Connected in 2026-Q4. A quantified return on the AI investment, in saved costs or gained productivity, appears on none of the four calls.
Management promises
-
2026-Q2 open
Dedicated resources will be added to pursue synergistic acquisition opportunities.
Neither a team nor a further acquisition is mentioned on the 2026-Q3 or 2026-Q4 calls. No deadline was attached to the commitment, so it is not overdue.
-
2026-Q3 open
Integration of the technology acquisition closed in June 2025 is running ahead of plan, with returns matching optimistic expectations.
The acquisition is not mentioned again on the 2026-Q4 call. Evidence for the promised benefit is therefore missing, though not disproven either.
-
2026-Q4 open
Four large payer programs will launch in calendar 2026, including two new multiyear partnerships with top 10 national payers.
Datable and verifiable in autumn 2026. It is the most concrete commitment across the four calls and the first real test of management credibility.
-
2026-Q4 open
Bookings up 56 percent are expected to contribute meaningfully to revenue and profit in the back half of calendar 2026, with the elevated headcount normalising as deployments mature.
Testable on the 2027-Q2 and 2027-Q3 calls. If revenue growth stays at 7 percent, the bookings jump had no effect on the income statement.
Based on public earnings call transcripts. Reviewed: 4 transcripts 2025-Q3 through 2026-Q4.
Next Reporting Date
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.46 | 38.90 | 228 | 12.70 | 10.40 | 42 | 32 |
| 2025: Q1 | 0.51 | 35.70 | 232 | 11.70 | 11.40 | 23 | 14 |
| 2025: Q2 | 0.52 | 26.30 | 235 | 10.90 | 11.60 | 55 | 40 |
| 2025: Q3 | 0.54 | 20.00 | 240 | 6.80 | 11.60 | 25 | 15 |
| 2025: Q4 | 0.47 | 2.60 | 236 | 3.40 | 10.30 | 46 | 35 |
| 2026: Q1 | 0.61 | 19.20 | 249 | 7.40 | 12.50 | 30 | 20 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2017 | 519 | 48 | 29 | 1.51 | 52 | 139 | 235 |
| 2018 | 558 | 48 | 36 | 1.87 | 62 | 171 | 274 |
| 2019 | 596 | 62 | 47 | 2.46 | 79 | 195 | 318 |
| 2020 | 592 | 61 | 47 | 2.56 | 81 | 190 | 416 |
| 2021 | 553 | 59 | 46 | 2.50 | 94 | 220 | 425 |
| 2022 | 646 | 85 | 66 | 1.22 | 67 | 212 | 415 |
| 2023 | 719 | 85 | 66 | 1.26 | 82 | 202 | 394 |
| 2024 | 795 | 95 | 76 | 1.47 | 99 | 248 | 455 |
| 2025 | 896 | 121 | 95 | 1.83 | 127 | 322 | 546 |
| 2026 | 959 | 143 | 110 | 2.14 | 156 | 394 | 643 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Assessment: Opportunities & Risks
Three consecutive record years: revenue rose from $795.3 million through $895.6 million to $958.5 million across fiscal 2024 to 2026, and net income from $76.3 million through $95.2 million to $110.3 million. The net margin climbed from 9.6 to 11.5 percent because the higher-margin bill review business grew faster (up 15 percent to $362 million in fiscal 2026) than case management (up 3 percent to $596 million). No customer accounted for 10 percent or more of revenue.
As of March 31, 2026 the balance sheet carries $394.23 million of equity (a 61.3 percent ratio) and $233.07 million of cash with no financial debt whatsoever; the only long-term liability is $20.69 million of lease obligations. Operating cash flow rose to $155.64 million, leaving roughly $110.3 million free after $45.36 million of capital expenditure — effectively identical to reported net income.
Fiscal 2026 saw $56.21 million spent on 782,744 of the company's own shares at an average of $71.81. Because 332,497 shares were simultaneously created through options, the employee plan and one asset acquisition, the share count fell only from 51,359,544 to 50,909,297 — a net 0.88 percent. In effect every share that genuinely disappeared cost roughly $125. Over 30 years the programme adds up to 115,259,435 shares for $888 million.
The proxy statement of June 26, 2026 shows Jeffrey J. Michael holding 37.99 percent as of March 31, 2026, mostly through Corstar Holdings, Inc.; all ten officers and directors together hold 39.72 percent. The same document lists him as an independent director, as chair of the nomination and governance committee and as a member of the compensation committee; each of those committees met once during fiscal 2026. The free float is correspondingly tight and no analyst consensus exists.
Sarah Scott (49, with the company since 1999) took over as chief executive on July 1, 2026 from Michael G. Combs, who became executive chair at $25,000 a month (Form 8-K of June 1, 2026). The annual report filed ten days earlier still names Combs as chief executive in its risk factors. The succession is internal; the first quarter under new leadership ended June 30, 2026 and had not been reported as of July 26, 2026.
A market capitalisation of roughly $3.0 billion (50,691,185 shares at a closing price of $59.86 on July 24, 2026) equates to roughly 28 times diluted earnings of $2.14 per share and 7.8 times book value — demanding against 7 percent revenue growth, defensible against a 30.8 percent return on equity. For context: the stock closed at $77.42 on September 30, 2025 per the annual report cover page, and the company itself repurchased at an average of $71.81 during fiscal 2026. Insiders sold seven times in twelve months and bought not once.
CorVel appears in a turnaround scanner but is not a restructuring case: the year ended March 31, 2026 was the best in company history with $958.5 million of revenue, $110.3 million of net income and $155.6 million of operating cash flow, on a balance sheet carrying 61.3 percent equity and no financial debt. What fell is the price, not the business — and that makes the decision harder, not easier, because there is no repair to bet on. Three points remain uncomfortable: a $56.2 million buyback that cut the share count by only 0.88 percent, a shareholder holding 37.99 percent who also chairs the nominating committee, and insiders who sold seven times in twelve months and bought not once. Not investment advice.
- CorVel reached our research list through our in-house stock scanner "Turnaround Candidates": rank 15 of 62 U.S. hits, turnaround check 7 of 8, as of July 25, 2026. These lists are recalculated daily, so the ranking is a dated snapshot. The load-bearing mandatory pillar is the requirement to trade at least 50 percent below the all-time high; if the stock rises above roughly $64, CorVel leaves this list without anything having changed in the business.
- The fiscal year ends March 31. References to "fiscal 2026" cover April 1, 2025 through March 31, 2026 (annual report filed May 22, 2026). That annual report is the most recent periodic filing; the quarterly report for the period ended June 30, 2026 had not been filed as of July 26, 2026.
- Price figures are dated valuation anchors, not buy arguments: closing price $59.86 on July 24, 2026, split-adjusted all-time high $128.46 on February 5, 2025, 52-week low $46.00 on February 9, 2026. All prices before December 26, 2024 are comparable only on a split-adjusted basis because of the three-for-one stock split.
- As of July 26, 2026 no takeover, merger or take-private process is under way: the company's SEC record contains no Form S-4, no Schedule 13E-3, no merger proxy, no Form 25 and no Form 15.
- Possible confusion: CorVel Corporation (CRVL) is not related to similarly named medical technology suppliers, and it is not Corstar Holdings, Inc. — Corstar is the major shareholder, not the operating business.
About the Company
CorVel Corporation bietet Lösungen für Arbeitsunfallversicherung, allgemeine und Kfz-Haftpflicht sowie Krankenhausrechnungsprüfung und Zahlungsintegrität. Sie setzt Technologie ein, darunter Künstliche Intelligenz, maschinelles Lernen und Verarbeitung natürlicher Sprache, um die Steuerung von Versorgungsepisoden zu verbessern und…
| Employees | 5,239 |
|---|---|
| Headquarters | Fort Worth, TX |
| Address | 5128 Apache Plume Road, 76109 Fort Worth, United States |
| Phone | 817 390 1416 |
| Website | corvel.com |
| IPO Date | 28. Jun 1991 |
| ISIN | US2210061097 |
| Stock Split | 3:1 on 12/26/2024 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Michael G. Combs | Executive Chair | 1964 |
| Brian S. Nichols | Chief Financial Officer | 1981 |
| Jennifer L. Yoss | Vice President of Accounting | 1978 |
| Maxim Shishin | Chief Information Officer | 1975 |
| Mark E. Bertels | Executive Vice President of Risk Management Services | 1963 |
| Sarah Scott | President & CEO | 1977 |
| Sharon F. O'Connor | Vice President of Legal Services | – |
| Melissa Storan | Vice President of Marketing | – |
| Jason Wheeler | Vice President of Sales & Account Management | – |
| Jeffrey D. Gurtcheff | Chief Claims Officer | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 29. Jul 2026 | Bertels Mark E. | EVP - Risk Management Services | Other | 33 | 62.25 | 2,054 |
| 29. Jul 2026 | Bertels Mark E. | EVP - Risk Management Services | Other | 634 | 62.25 | 39,467 |
| 29. Jul 2026 | Bertels Mark E. | EVP - Risk Management Services | Other | 750 | 52.65 | 39,485 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.